Paul Ingravallo

2.9k total citations
30 papers, 1.6k citations indexed

About

Paul Ingravallo is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Paul Ingravallo has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 14 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Paul Ingravallo's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (11 papers). Paul Ingravallo is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (11 papers). Paul Ingravallo collaborates with scholars based in United States, Brazil and United Kingdom. Paul Ingravallo's co-authors include John W. Barnwell, Mary R. Galinski, Masanori Aikawa, Julian C. Rayner, M. Yamaya, Ralph L. Nachman, Adam S. Asch, Francine B. Perler, Ernest Asante‐Appiah and Frederick Lahser and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paul Ingravallo

30 papers receiving 1.6k citations

Peers

Paul Ingravallo
Comparison fields: 5 of 72
  • Public Health, Environmental and Occupational Health 1.0k
  • Immunology 529
  • Epidemiology 377
  • Hepatology 347
  • Molecular Biology 243
Francis Fumoux France
Nicola K. Viebig Germany
Benoît Gamain France
Christian Roussilhon France
Robert Schwenk United States
Mafalda Resende Denmark
Christine Langer Australia
Bruno Pouvelle France
Ronald Perraut Senegal
Claire Hutchings United Kingdom
Francis Fumoux France View profile →
Citations per field, relative to Paul Ingravallo
Paul Ingravallo · 1×
Citations per year, relative to Paul Ingravallo
Paul Ingravallo · 1×

Countries citing papers authored by Paul Ingravallo

Since Specialization
Citations

This map shows the geographic impact of Paul Ingravallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ingravallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ingravallo more than expected).

Fields of papers citing papers by Paul Ingravallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ingravallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ingravallo. The network helps show where Paul Ingravallo may publish in the future.

Co-authorship network of co-authors of Paul Ingravallo

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Ingravallo. A scholar is included among the top collaborators of Paul Ingravallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Ingravallo. Paul Ingravallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse Infection and Drug Resistance David Bonsall, Stuart Black et al. 7
2 Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus Antiviral Research Shuntai Zhou, David R. McGivern et al. 4
3 Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a Journal of Biological Chemistry Zhuyan Guo, Stuart Black et al. 8
4 Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B Bioorganic & Medicinal Chemistry Letters Nanjing Zhang, Anthony Turpoff et al. 10
5 Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors Gastroenterology David R. McGivern, Takahiro Masaki et al. 84
6 858 IN VITRO RESISTANCE ANALYSIS OF HCV NS5A INHIBITOR: MK-8742 DEMONSTRATES INCREASED POTENCY AGAINST CLINICAL RESISTANCE VARIANTS AND HIGHER RESISITANCE BARRIER Journal of Hepatology Rong Kong, Paul Ingravallo et al. 9
7 A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry Antiviral Research Rong Kong, Rumin Zhang et al. 22
8 Screening for Antiviral Inhibitors of the HIV Integrase–LEDGF/p75 Interaction Using the AlphaScreen™ Luminescent Proximity Assay SLAS DISCOVERY Yan Hou, Andrew Prongay et al. 40
9 In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease Journal of Antimicrobial Chemotherapy Rong Liu, Karim Abid et al. 13
10 Plasmodium vivax merozoite surface protein PvMSP-3β is radically polymorphic through mutation and large insertions and deletions Infection Genetics and Evolution Julian C. Rayner, Curtis S. Huber et al. 48
11 Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum☆ Molecular and Biochemical Parasitology John W. Barnwell, Paul Ingravallo et al. 47
12 Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3α is limited to specific domains Parasitology Julian C. Rayner, Vladimir Corredor et al. 69
13 Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase Virus Research Paul Ingravallo, Frederick Lahser et al. 4
14 Plasmodium vivax merozoite surface proteins-3β and-3γ share structural similarities with P. vivax merozoite surface protein-3α and define a new gene family Molecular and Biochemical Parasitology Mary R. Galinski, Paul Ingravallo et al. 56
15 Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3 Journal of Virology Nancy Butkiewicz, Nanhua Yao et al. 36
16 Plasmodium vivax, P. cynomolgi, andP. knowlesi:Identification of Homologue Proteins Associated with the Surface of Merozoites Experimental Parasitology John W. Barnwell, Mary R. Galinski et al. 49
17 Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain Molecular and Biochemical Parasitology Mary R. Galinski, Juan A. Crosby et al. 91
18 A reticulocyte-binding protein complex of plasmodium vivax merozoites Cell Mary R. Galinski, Paul Ingravallo et al. 297
19 Plasmodium vivax: Malarial proteins associated with the membrane-bound caveola-vesicle complexes and cytoplasmic cleft structures of infected erythrocytes Experimental Parasitology John W. Barnwell, Paul Ingravallo et al. 34
20 A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. Journal of Clinical Investigation John W. Barnwell, Adam S. Asch et al. 314

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026